Filipits M - Search Results

1

Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.

Filipits M, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R. Filipits M, et al. Clin Cancer Res. 1997 Aug;3(8):1419-25. Clin Cancer Res. 1997. PMID: 9815827 Clinical Trial.

2

Clinical relevance of drug resistance genes in malignant disease.

Filipits M, Suchomel RW, Zöchbauer S, Malayeri R, Pirker R. Filipits M, et al. Leukemia. 1996 Jul;10 Suppl 3:S10-S17. Leukemia. 1996. PMID: 8656694 Review.

3

Multidrug resistance in leukemias and its reversal.

Malayeri R, Filipits M, Suchomel RW, Zöchbauer S, Lechner K, Pirker R. Malayeri R, et al. Among authors: filipits m. Leuk Lymphoma. 1996 Nov;23(5-6):451-8. doi: 10.3109/10428199609054853. Leuk Lymphoma. 1996. PMID: 9031075 Review.

4

Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status.

Filipits M, Suchomel RW, Lechner K, Pirker R. Filipits M, et al. Leukemia. 1997 Jul;11(7):1073-7. doi: 10.1038/sj.leu.2400655. Leukemia. 1997. PMID: 9204994

5

Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia.

Filipits M, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Pirker R. Filipits M, et al. Blood. 1998 Mar 1;91(5):1508-13. Blood. 1998. PMID: 9473213 Free article.

6

MRP and MDR1 gene expression in primary breast carcinomas.

Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, Pirker R. Filipits M, et al. Clin Cancer Res. 1996 Jul;2(7):1231-7. Clin Cancer Res. 1996. PMID: 9816292

7

Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.

Filipits M, Drach J, Pohl G, Schuster J, Stranzl T, Ackermann J, Königsberg R, Kaufmann H, Gisslinger H, Huber H, Ludwig H, Pirker R. Filipits M, et al. Clin Cancer Res. 1999 Sep;5(9):2426-30. Clin Cancer Res. 1999. PMID: 10499614 Clinical Trial.

8

The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia.

Pirker R, Pohl G, Stranzl T, Suchomel RW, Scheper RJ, Jäger U, Geissler K, Lechner K, Filipits M. Pirker R, et al. Among authors: filipits m. Adv Exp Med Biol. 1999;457:133-9. doi: 10.1007/978-1-4615-4811-9_15. Adv Exp Med Biol. 1999. PMID: 10500788

9

MRP expression in acute myeloid leukemia. An update.

Filipits M, Stranzl T, Pohl G, Suchomel RW, Zöchbauer S, Brunner R, Lechner K, Pirker R. Filipits M, et al. Adv Exp Med Biol. 1999;457:141-50. doi: 10.1007/978-1-4615-4811-9_16. Adv Exp Med Biol. 1999. PMID: 10500789

10

Drug resistance factors in acute myeloid leukemia: a comparative analysis.

Filipits M, Stranzl T, Pohl G, Heinzl H, Jäger U, Geissler K, Fonatsch C, Haas OA, Lechner K, Pirker R. Filipits M, et al. Leukemia. 2000 Jan;14(1):68-76. doi: 10.1038/sj.leu.2401634. Leukemia. 2000. PMID: 10637479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters